HCA Healthcare (NYSE:HCA) Given New $390.00 Price Target at Truist Financial

HCA Healthcare (NYSE:HCA) had its price objective trimmed by Truist Financial from $430.00 to $390.00 in a report released on Monday morning,Benzinga reports. The firm currently has a buy rating on the stock.

Other equities analysts have also issued research reports about the company. Morgan Stanley cut their price target on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a research note on Tuesday, October 1st. KeyCorp reduced their price objective on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a research report on Monday, October 28th. StockNews.com cut shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Finally, Barclays lowered their price objective on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a report on Friday, November 8th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $388.60.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $296.45 on Monday. The company’s fifty day moving average price is $325.72 and its 200 day moving average price is $354.69. The company has a market capitalization of $75.09 billion, a PE ratio of 13.31, a price-to-earnings-growth ratio of 1.21 and a beta of 1.64. HCA Healthcare has a 1 year low of $276.50 and a 1 year high of $417.14. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, December 27th. Shareholders of record on Friday, December 13th were paid a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.89%. The ex-dividend date was Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.85%.

Insider Transactions at HCA Healthcare

In related news, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now directly owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

Hedge Funds Weigh In On HCA Healthcare

A number of hedge funds and other institutional investors have recently bought and sold shares of HCA. FMR LLC boosted its stake in shares of HCA Healthcare by 322.3% in the third quarter. FMR LLC now owns 3,141,769 shares of the company’s stock valued at $1,276,909,000 after purchasing an additional 2,397,883 shares during the period. Franklin Resources Inc. boosted its position in HCA Healthcare by 11.7% in the 3rd quarter. Franklin Resources Inc. now owns 1,669,721 shares of the company’s stock valued at $660,842,000 after buying an additional 174,946 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of HCA Healthcare by 2.8% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,487,367 shares of the company’s stock worth $604,511,000 after acquiring an additional 41,190 shares during the period. Janus Henderson Group PLC grew its stake in HCA Healthcare by 12.0% during the 3rd quarter. Janus Henderson Group PLC now owns 1,339,638 shares of the company’s stock worth $544,467,000 after purchasing an additional 143,995 shares in the last quarter. Finally, Darsana Capital Partners LP boosted its stake in shares of HCA Healthcare by 53.3% in the 2nd quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock valued at $369,472,000 after buying an additional 400,000 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.